Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022052290> ?p ?o ?g. }
- W2022052290 endingPage "315" @default.
- W2022052290 startingPage "301" @default.
- W2022052290 abstract "Chymase possesses a wide variety of actions, including promotion of angiotensin II production and histamine release from mast cells. However, due to a lack of effective inhibitors featuring both high inhibitory activity and high metabolic stability, the pathophysiological role of chymase has not been fully elucidated. We designed non-peptidic inhibitors based on the predicted binding mode of the peptidic chymase inhibitor Val-Pro-Phe-CF3 and demonstrated that the Val-Pro unit is replaceable with a (5-amino-6-oxo-2-phenyl-1,6-dihydro-1-pyrimidinyl)acetyl moiety. Structure–activity relationship studies revealed that phenyl substitution at the 2-position of the pyrimidinone ring is indispensable for high activity. The most potent compound 1h (Ki=0.0506 μM) is superior in potency to the parent peptidic inhibitor Val-Pro-Phe-CF3 and has good selectivity for chymase over other proteases. The related analogue 1e was orally absorbed and maintained high plasma levels for at least 2 h. These results suggest that the derivatives reported here could be developed as agents for treatment of chymase-induced disease." @default.
- W2022052290 created "2016-06-24" @default.
- W2022052290 creator A5013155553 @default.
- W2022052290 creator A5017133102 @default.
- W2022052290 creator A5023452891 @default.
- W2022052290 creator A5023491897 @default.
- W2022052290 creator A5038500312 @default.
- W2022052290 creator A5042195173 @default.
- W2022052290 creator A5047596853 @default.
- W2022052290 creator A5054049580 @default.
- W2022052290 creator A5054579480 @default.
- W2022052290 creator A5059793602 @default.
- W2022052290 creator A5059808683 @default.
- W2022052290 date "2001-02-01" @default.
- W2022052290 modified "2023-10-02" @default.
- W2022052290 title "Non-Peptidic inhibitors of human chymase. Synthesis, structure–activity relationships, and pharmacokinetic profiles of a series of 5-amino-6-oxo-1,6-dihydropyrimidine-containing trifluoromethyl ketones" @default.
- W2022052290 cites W1016700589 @default.
- W2022052290 cites W1502459074 @default.
- W2022052290 cites W1521804991 @default.
- W2022052290 cites W1587501715 @default.
- W2022052290 cites W1965341645 @default.
- W2022052290 cites W1966331330 @default.
- W2022052290 cites W1968308873 @default.
- W2022052290 cites W1973909424 @default.
- W2022052290 cites W1975586649 @default.
- W2022052290 cites W1988844190 @default.
- W2022052290 cites W1993585253 @default.
- W2022052290 cites W1994617822 @default.
- W2022052290 cites W1996690543 @default.
- W2022052290 cites W2010138952 @default.
- W2022052290 cites W2016250281 @default.
- W2022052290 cites W2016803638 @default.
- W2022052290 cites W2022919284 @default.
- W2022052290 cites W2027309030 @default.
- W2022052290 cites W2029389633 @default.
- W2022052290 cites W2040583218 @default.
- W2022052290 cites W2043138008 @default.
- W2022052290 cites W2049962531 @default.
- W2022052290 cites W2050263498 @default.
- W2022052290 cites W2065529096 @default.
- W2022052290 cites W2065625486 @default.
- W2022052290 cites W2069401173 @default.
- W2022052290 cites W2072810181 @default.
- W2022052290 cites W2078859050 @default.
- W2022052290 cites W2081124060 @default.
- W2022052290 cites W2082230373 @default.
- W2022052290 cites W2088771184 @default.
- W2022052290 cites W2091159018 @default.
- W2022052290 cites W2109882819 @default.
- W2022052290 cites W2122485484 @default.
- W2022052290 cites W2136058654 @default.
- W2022052290 cites W2143658570 @default.
- W2022052290 cites W2155326631 @default.
- W2022052290 cites W2462703090 @default.
- W2022052290 doi "https://doi.org/10.1016/s0968-0896(00)00244-3" @default.
- W2022052290 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11249123" @default.
- W2022052290 hasPublicationYear "2001" @default.
- W2022052290 type Work @default.
- W2022052290 sameAs 2022052290 @default.
- W2022052290 citedByCount "11" @default.
- W2022052290 countsByYear W20220522902014 @default.
- W2022052290 countsByYear W20220522902020 @default.
- W2022052290 crossrefType "journal-article" @default.
- W2022052290 hasAuthorship W2022052290A5013155553 @default.
- W2022052290 hasAuthorship W2022052290A5017133102 @default.
- W2022052290 hasAuthorship W2022052290A5023452891 @default.
- W2022052290 hasAuthorship W2022052290A5023491897 @default.
- W2022052290 hasAuthorship W2022052290A5038500312 @default.
- W2022052290 hasAuthorship W2022052290A5042195173 @default.
- W2022052290 hasAuthorship W2022052290A5047596853 @default.
- W2022052290 hasAuthorship W2022052290A5054049580 @default.
- W2022052290 hasAuthorship W2022052290A5054579480 @default.
- W2022052290 hasAuthorship W2022052290A5059793602 @default.
- W2022052290 hasAuthorship W2022052290A5059808683 @default.
- W2022052290 hasConcept C1122143 @default.
- W2022052290 hasConcept C112705442 @default.
- W2022052290 hasConcept C114373084 @default.
- W2022052290 hasConcept C116073593 @default.
- W2022052290 hasConcept C178790620 @default.
- W2022052290 hasConcept C181199279 @default.
- W2022052290 hasConcept C182220744 @default.
- W2022052290 hasConcept C185592680 @default.
- W2022052290 hasConcept C193042331 @default.
- W2022052290 hasConcept C202751555 @default.
- W2022052290 hasConcept C2776442012 @default.
- W2022052290 hasConcept C2776568683 @default.
- W2022052290 hasConcept C2776980637 @default.
- W2022052290 hasConcept C2780263894 @default.
- W2022052290 hasConcept C2780614898 @default.
- W2022052290 hasConcept C55493867 @default.
- W2022052290 hasConcept C57992300 @default.
- W2022052290 hasConcept C71240020 @default.
- W2022052290 hasConcept C71924100 @default.
- W2022052290 hasConcept C98274493 @default.
- W2022052290 hasConceptScore W2022052290C1122143 @default.
- W2022052290 hasConceptScore W2022052290C112705442 @default.
- W2022052290 hasConceptScore W2022052290C114373084 @default.
- W2022052290 hasConceptScore W2022052290C116073593 @default.